- Biocon Biologics has launched Yesintek™ (ustekinumab-kfce), a biosimilar to Stelara®, in the United States.
- Yesintek is approved for treating Crohn’s disease, ulcerative colitis, plaq…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]